Dotbee.ai

Analysis Livzon Pharmaceutical Group Inc. (LVZPF)

5/25/2024

Analysis Livzon Pharmaceutical Group Inc. (LVZPF)

Analysis of Livzon Pharmaceutical Group Inc. (LVZPF)

Livzon Pharmaceutical Group Inc. (LVZPF) has been showing a consistent price of 3.20 over the past several days. The Relative Strength Index (RSI) indicator is at 100.00, indicating that the stock may be overbought. The Moving Average Convergence Divergence (MACD) indicator is showing a slight decrease in momentum, with the MACD line below the signal line.

The Moving Average (MA) indicator is also at 3.20, matching the current price. The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are all in close proximity to the current price, indicating stability in the trend.

Overall, Livzon Pharmaceutical Group Inc. seems to be trading at a stable price with some signs of overbought conditions. Traders and investors may want to monitor the RSI and MACD indicators for potential shifts in momentum.

Revenue estimate

Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:

1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.

2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.

3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.

4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.

These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.

Growth estimates

Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:

1. The current year growth rate is estimated to be 7.5%.
2. The next quarter growth rate is projected to be 4.8%.
3. The current quarter growth rate is expected to be 5.6%.
4. The next year growth rate is forecasted to be 9.7%.
5. The average annual growth rate for the next 5 years is estimated to be 11%.
6. The average annual growth rate for the past 5 years was approximately 20.15%.

These estimates suggest that the company is expected to experience moderate growth in the short term, with a slightly higher growth rate projected for the next year. However, the long-term outlook appears more optimistic, with a higher average annual growth rate anticipated over the next 5 years compared to the past 5 years.

Price target

Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57.

Earnings

The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released After Hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.33.

Main Statystic 🧠

The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company. Here is a summary of the key data points:

1. Financials:
- Cash Flow: Operating cash flow TTM is $110,563,000,320 and levered free cash flow TTM is $84,726,874,112.
- Balance Sheet: Total cash MRQ is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, and total debt to equity MRQ is 140.968.
- Profit Margin: 26.306%
- Fiscal Year Ends: September 30, 2023
- Income Statement: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.44, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating Margin: 30.743%
- Return on Assets TTM: 22.073999%
- Return on Equity TTM: 147.25%

2. Stock Statistics:
- Short Ratio: 1.66
- Float Shares: 15,308,320,742
- Shares Short: 94,308,265
- Avg 10 Volume: 52,903,608
- Avg 90 Volume: 62,823,269
- Shares Outstanding: 15,334,099,968
- Percent Held by Insiders: 5.22%
- Percent Held by Institutions: 57.555%
- Short Percent of Shares Outstanding: 0.62%

3. Valuation Metrics:
- PEG Ratio: 26.213001
- Forward PE: 26.213001
- Trailing PE: 29.428572
- Enterprise Value: $2,948,462,018,560
- Price to Book MRQ: 39.181313
- Price to Sales TTM: 7.6151557
- Enterprise to EBITDA: 22.745
- Enterprise to Revenue: 7.726
- Market Capitalization: $2,906,118,684,672

4. Stock Price Summary:
- Beta: 1.264
- Day 50 MA: 173.6936
- Day 200 MA: 180.7906
- Fifty-Two Week Low: $164.08
- Fifty-Two Week High: $199.62
- Fifty-Two Week Change: 8.253%

5. Dividends and Splits:
- Payout Ratio: 14.93%
- Dividend Date: May 16, 2024
- Last Split Date: August 31, 2020
- Ex-Dividend Date: May 10, 2024
- Last Split Factor: 4-for-1 split
- Forward Annual Dividend Rate: $1
- 5-Year Average Dividend Yield: 0.73%
- Forward Annual Dividend Yield: 0.5266761603816345%
- Trailing Annual Dividend Rate: $0.97
- Trailing Annual Dividend Yield: 0.5108758755701854%

Income statement 💸

These are the revenue figures. Here are the conclusions:

1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been relatively stable, with gross profit ranging from around $105 billion to $169 billion.
3. Operating income has also shown an increasing trend, from $66.3 billion in 2020 to $114.3 billion in 2023.
4. Net income has been on the rise, reaching $97 billion in 2023 from $57.4 billion in 2020.
5. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years.
6. The company has been able to manage its operating expenses effectively, as seen in the growth of operating income outpacing the increase in operating expenses.
7. The company has been able to maintain a healthy EBITDA margin, with EBITDA increasing from $81 billion in 2020 to $129.2 billion in 2023.
8. Despite an increase in income tax expenses, the company's net income has continued to grow, indicating efficient tax management strategies.
9. Overall, the financial performance of the company in terms of revenue and profitability has been positive and improving over the years.

Balance Sheet

These are balance sheets. Here are the conclusions:

1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,755,000,000.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2023 at $217,350,000,000.
4. Total liabilities have also been increasing, reaching the highest value in 2023 at $302,083,000,000.
5. Shareholders' equity has been fluctuating, with the highest value in 2023 at $73,812,000,000.
6. The company has been relying more on non-current assets and debt to finance its operations over the years.

Cash Flow 💶

This is the cash flow statement. Here are some conclusions we can draw from the data:

1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been relatively stable over the years, indicating consistent operational performance.
3. The company has been paying a significant amount in income taxes each year, with a slight decrease in 2020.
4. Interest paid has also varied over the years, with a notable increase in 2023.
5. The company has been actively involved in financing activities, including common stock repurchases, debt issuances, and dividend payments.
6. Investing activities show a mix of acquisitions, investments, and capital expenditures over the years.
7. The end cash position has fluctuated, reaching its highest value in 2020.
8. Stock-based compensation has been a significant factor in the company's financial activities.
9. The company has been managing its cash flow effectively to maintain a healthy financial position despite fluctuations in free cash flow.

Earnings estimate

The analysts' estimates for future quarterly and annual earnings per share are as follows:

1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26

2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25

3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39

4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39

Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two years. The average estimates show an increase compared to the year-ago EPS figures, indicating potential growth in earnings for the company.

MACD of LVZPF

This is not investment advice. Remember to verify the information provided here.

Get access to the full analysis

  • Over 35 000 indexes
  • CFD, Forex, Crypto and Stocks Exchange
  • Over 150 Indicators
  • Pattern and candle analysis
  • Support and resistance levels
  • Fundamental, technical and sentimental analysis
  • Power from AI
Web versionApp StoreGoogle Play

Contacts

Telephone number

+48 32 700 81 66

Email address

[email protected]

Company information

Honey Payment Group S.A. at Al. Aleje Jerozolimskie 65 / 79, 00-697 Warsaw, Poland, Register number KRS 0000335507, NIP 5252859204, REGON 388760204. Honey Payment Group is listed on the Warsaw Stock Exchange (WSE) under the ticker symbol HPG. Link